Cite
18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data
MLA
Thomas W. Barber, et al. “18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 53, no. 6, May 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b429e22011e5eafbc570b71f1355e0c4&authtype=sso&custid=ns315887.
APA
Thomas W. Barber, Elizabeth Drummond, Rodney J. Hicks, Trevor Leong, Cuong Duong, & Mathias Bressel. (2012). 18F-FDG PET/CT has a high impact on patient management and provides powerful prognostic stratification in the primary staging of esophageal cancer: a prospective study with mature survival data. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 53(6).
Chicago
Thomas W. Barber, Elizabeth Drummond, Rodney J. Hicks, Trevor Leong, Cuong Duong, and Mathias Bressel. 2012. “18F-FDG PET/CT Has a High Impact on Patient Management and Provides Powerful Prognostic Stratification in the Primary Staging of Esophageal Cancer: A Prospective Study with Mature Survival Data.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 53 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b429e22011e5eafbc570b71f1355e0c4&authtype=sso&custid=ns315887.